Systematic Review of the Performance of Rapid Rifampicin Resistance Testing for Drug-Resistant Tuberculosis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Arentz, Matthew ^a   Sorensen, Bess ^a   Horne, David J ^a   Walson, Judd L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG RESISTANT TUBERCULOSIS; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; PREDICTIVE VALUE; PREVALENCE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TUBERCULOSIS RAPID TEST;

ANTITUBERCULAR AGENTS; BIAS (EPIDEMIOLOGY); DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84884878053     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076533     Document Type: Article

References (27)

1. WHO (2011) Global Tuberculosis Control 2011. Geneva, Switzerland: World Health Organization.
2. Arentz M, Walson JL, (2011) Tuberculosis. In: HAaMeds., Juergensmeyer. The Encyclopedia of Global Studies. Thousand Oaks, CA: Sage Publications.
3. WHO (2011) Guidelines for the progrommatic management of drug-resistant tuberculosis: 2011 update. Geneva, Switzerland: World Health Organization.
4. WHO (2008) Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. Geneva, Switzerland: World Health Organization.
5. Bwanga F, Hoffner S, Haile M, Joloba ML, (2009) Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 9: 67. doi:10.1186/1471-2334-9-67. PubMed: 19457256.
6. Chang KC, Yew WW, Zhang Y, (2009) A systematic review of rapid drug suscepbility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogate. Expert Opin Med Diagn 3: 99-122. doi:10.1517/17530050802665694. PubMed: 23485158.
7. Macaskill P, [!(surname)!], Deeks JJ, Harbord RM, Takwoingi Y, (2010) Analysing and Presenting Results10. In: Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Chapter Version 0.9.0 Deeks JJ BP, Gatsonis C editor: The Cochrane Collaboration.
8. Ling DI, Zwerling AA, Pai M, (2008) GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 32: 1165-1174. doi:10.1183/09031936.00061808. PubMed: 18614561.
9. Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino JC, et al. (2008) The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 62: 56-64. doi:10.1093/jac/dkn139. PubMed: 18407918.
10. Martin A, Portaels F, Palomino JC, (2007) Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 59: 175-183. PubMed: 17135182.
11. Minion J, Leung E, Menzies D, Pai M, (2010) Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 10: 688-698. doi:10.1016/S1473-3099(10)70165-1. PubMed: 20813587.
12. Morgan M, Kalantri S, Flores L, Pai M, (2005) A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 5: 62. doi:10.1186/1471-2334-5-62. PubMed: 16050959.
13. Leung E, Minion J, Benedetti A, Pai M, Menzies D, (2012) Microcolony culture techniques for tuberculosis diagnosis: a systematic review. Int J Tuberc Lung Dis 16: 16-23, i-iii doi:10.5588/ijtld.10.0065. PubMed: 21986554.
14. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62: 1006-1012. doi:10.1016/j.jclinepi.2009.06.005. PubMed: 19631508.
15. WHO (2011) Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement. Geneva.
16. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, et al. (2013) Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1CD009593.
17. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155: 529-536. doi:10.7326/0003-4819-155-8-201110180-00009. PubMed: 22007046.
18. StataCorp, (2009) Stata Statistical Software, Release 11. TX: College Station.
19. Collaboration TC (2011). Rev Manag (RevMan). 5.1 ed. Copenhagen: The Nordic Cochrane Center.
20. Rutter CM, Gatsonis CA, (2001) A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 20: 2865-2884. doi:10.1002/sim.942. PubMed: 11568945.
21. Macaskill P, [!(surname)!], Deeks JJ, Harbord RM, Takwoingi Y, (2010) Analysing and Presenting Results. In: Cochrane handbook for systematic reviews of diagnostic test accuracy. London: The Cochrane Collaboration.
22. Tatsioni A, Zarin DA, Aronson N, Samson DJ, Flamm CR, et al. (2005) Challenges in systematic reviews of diagnostic technologies. Ann Intern Med 142: 1048-1055. doi:10.7326/0003-4819-142-12_Part_2-200506211-00004. PubMed: 15968029.
23. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336: 924-926. doi:10.1136/bmj.39489.470347.AD. PubMed: 18436948.
24. Brozek J, [!(surname)!], Schünemann H, (2008) GRADEpro, 3.6 for Windows ed. McMaster University.
25. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-1505. doi:10.1016/S0140-6736(11)60438-8. PubMed: 21507477.
26. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, et al. (2011) Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLOS Med 8: e1001067. PubMed: 21818180.
27. Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP, (2012) Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. Int J Tuberc Lung Dis 16: 203-205. doi:10.5588/ijtld.11.0445. PubMed: 22136739.